Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 8, 2012, Pages 1242-1248

  van den Brand, Jan A J G ^a   Hofstra, Julia M ^a   Wetzels, Jack F M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BETA 2 MICROGLOBULIN URINE LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIURETIC THERAPY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; IDIOPATHIC MEMBRANOUS NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MOLECULAR WEIGHT; NEPHROTIC SYNDROME; PHASE 3 CLINICAL TRIAL; PREDICTIVE VALUE; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TORONTO RISK SCORE; URINALYSIS;

ADULT; AGED; ALPHA-GLOBULINS; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; BIOPSY; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINURIA; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84864827238     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00670112     Document Type: Article

References (21)

1. du Buf-Vereijken PW, Branten AJ, Wetzels JF: Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy. Am J Kidney Dis 46: 1012-1029, 2005
2. van den Brand JAJG, Hofstra JM, Wetzels JFM: Low-molecularweight proteins as prognostic markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6: 2846-2853, 2011
3. Pei Y, Cattran D, Greenwood C: Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 42: 960-966, 1992
4. Cattran DC, Pei Y, Greenwood CM, Ponticelli C, Passerini P, Honkanen E: Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications. Kidney Int 51: 901-907, 1997
5. Honkanen E, Teppo AM, Meri S, Lehto T, Grönhagen-Riska C: Urinary excretion of cytokines and complement SC5b-9 in idiopathic membranous glomerulonephritis. Nephrol Dial Transplant 9: 1553-1559, 1994
6. Kon SP, Coupes B, Short CD, Solomon LR, Raftery MJ, Mallick NP, Brenchley PE: Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy. Kidney Int 48: 1953-1958, 1995
7. Honkanen E, Teppo AM, Törnroth T, Groop PH, Grönhagen-Riska C: Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. Nephrol Dial Transplant 12: 2562-2568, 1997
8. Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G: Urinary N-acetyl-beta-glucosaminidase excretion is amarker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Nephrol Dial Transplant 17: 1890-1896, 2002
9. Ponticelli C, Passerini P: Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy? J Nephrol 23: 156-163, 2010
10. Branten AJ, du Buf-VereijkenPW, Klasen IS, Bosch FH, FeithGW, Hollander DA, Wetzels JF: Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: Avalidation study. J AmSoc Nephrol 16: 169-174, 2005
11. Hofstra JM, Deegens JK, Willems HL, Wetzels JF: Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Nephrol Dial Transplant 23: 2546-2551, 2008
12. Hofstra JM, Wetzels JF: Management of patients with membranous nephropathy. Nephrol Dial Transplant 27: 6-9, 2012
13. Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF: Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: A randomized controlled trial. Nephrol Dial Transplant 25: 129-136, 2010
14. Jacobs EM, Vervoort G, Branten AJ, Klasen I, Smits P, Wetzels JF: Atrial natriuretic peptide increases albuminuria in type I diabetic patients: Evidence for blockade of tubular protein reabsorption. Eur J Clin Invest 29: 109-115, 1999
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999
16. Hofstra JM, Willems JL, Wetzels JF: Estimated glomerular filtration rate in the nephrotic syndrome. Nephrol Dial Transplant 26: 550-556, 2011
17. Hofstra JM, Deegens JK, Steenbergen EJ, Wetzels JF: Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy. Nephrol Dial Transplant 23: 3160-3165, 2008
18. Pencina MJ, D'Agostino RB, Vasan RS: Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med 48: 1703-1711, 2010
19. Reichert LJ, Koene RA, Wetzels JF: Prognostic factors in idiopathic membranous nephropathy. Am J Kidney Dis 31: 1-11, 1998
20. Troyanov S, Roasio L, Pandes M, Herzenberg AM, Cattran DC: Renal pathology in idiopathic membranous nephropathy: A new perspective. Kidney Int 69: 1641-1648, 2006
21. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ: Antiphospholipase A receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6: 1286-1291, 2011